Search Results - "MAERTEN, P"

Refine Results
  1. 1

    Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept by Shen, C., Assche, G. V., Colpaert, S., Maerten, P., Geboes, K., Rutgeerts, P., Ceuppens, J. L.

    Published in Alimentary pharmacology & therapeutics (01-02-2005)
    “…Summary Background : Adalimumab, a fully human monoclonal antibody to tumour necrosis factor, was recently introduced for therapy of Crohn's disease. Aim :…”
    Get full text
    Journal Article
  2. 2

    B7 Interactions with CD28 and CTLA-4 Control Tolerance or Induction of Mucosal Inflammation in Chronic Experimental Colitis by Liu, Zhanju, Geboes, Karel, Hellings, Peter, Maerten, Philippe, Heremans, Hubertine, Vandenberghe, Peter, Boon, Louis, van Kooten, Peter, Rutgeerts, Paul, Ceuppens, Jan L

    Published in The Journal of immunology (1950) (01-08-2001)
    “…CD28-B7 interaction plays a critical costimulatory role in inducing T cell activation, while CTLA-4-B7 interaction provides a negative signal that is essential…”
    Get full text
    Journal Article
  3. 3

    Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models by MAERTEN, P., SHEN, C., COLPAERT, S., LIU, Z., BULLENS, D. A. M., VAN ASSCHE, G., PENNINCKX, F., GEBOES, K., VANHAM, G., RUTGEERTS, P., CEUPPENS, J. L.

    Published in Clinical and experimental immunology (01-02-2004)
    “…SUMMARY An imbalance of immunoregulatory factors and/or cells contributes to uncontrolled mucosal T cell activation and inflammation in Crohn's disease (CD)…”
    Get full text
    Journal Article
  4. 4

    A single dose of intravenous esomeprazole decreases gastric secretion in healthy volunteers by NICHITA, C., ABDOU, A. E.‐W., MAERTEN, P., HERRANZ, M., MOURET, N., THALMANN, C., MICHETTI, P. F., DORTA, G.

    Published in Alimentary pharmacology & therapeutics (01-11-2009)
    “…Summary Background  Data suggest that esomeprazole decreases gastric secretion. Aims  To assess the effect of a single i.v. esomeprazole dose on gastric…”
    Get full text
    Journal Article
  5. 5

    Involvement of 4‐1BB (CD137)−4‐1BBligand interaction in the modulation of CD4+ T cell‐mediated inflammatory colitis by Maerten, P., Kwon, B. S., Shen, C., De Hertogh, G., Cadot, P., Bullens, D. M. A., Overbergh, L., Mathieu, C., Van Assche, G., Geboes, K., Rutgeerts, P., Ceuppens, J. L.

    Published in Clinical and experimental immunology (01-02-2006)
    “…Summary 4‐1BB ligand (4‐1BBL) expressed on antigen‐presenting cells interacts with 4‐1BB on activated T cells (especially CD8+ cells) and co‐stimulates the…”
    Get full text
    Journal Article
  6. 6

    Infliximab induces apoptosis of monocytes and T lymphocytes in a human–mouse chimeric model by Shen, Chong, Maerten, Philippe, Geboes, Karel, Van Assche, Gert, Rutgeerts, Paul, Ceuppens, Jan L.

    Published in Clinical immunology (Orlando, Fla.) (01-06-2005)
    “…Tumor necrosis factor (TNF) antagonism with monoclonal antibodies is an effective therapy for severe Crohn's disease and rheumatoid arthritis. Recent studies…”
    Get full text
    Journal Article
  7. 7

    Effects of interleukin 4 on CD25 +CD4 + regulatory T cell function by Maerten, Philippe, Shen, Chong, Bullens, Dominique M.A., Van Assche, Gert, Van Gool, Stefaan, Geboes, Karel, Rutgeerts, Paul, Ceuppens, Jan L.

    Published in Journal of autoimmunity (01-09-2005)
    “…CD25 +CD4 + regulatory T cells (Tregs) contribute to the maintenance of peripheral tolerance against self and non-self. The modulatory effects of cytokines,…”
    Get full text
    Journal Article
  8. 8

    Investigations for esophageal motility and reflux by Wiesel, P H, Maerten, P, Guyot, J

    Published in Revue médicale suisse (21-01-2009)
    “…High resolution manometry represents an interesting technological advance, facilitating the procedure, a continuous recording of the peristalsis on a single…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Acute gastrointestinal bleeding by Nichita, C, Maerten, P, Viani, F, Jornod, P, Dorta, G

    Published in Revue médicale suisse (27-01-2010)
    “…Gastrointestinal bleeding is among the major clinical challenges for the gastroenterologists and the initial approach is very complex. For a big part of…”
    Get more information
    Journal Article
  11. 11
  12. 12

    ORIGINAL ARTICLE: Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 super(+) T cell-mediated inflammatory colitis by Maerten, P, Kwon, B S, Shen, C, De Hertogh, G, Cadot, P, Bullens, DMA, Overbergh, L, Mathieu, C, Van Assche, G, Geboes, K, Rutgeerts, P, Ceuppens, J L

    Published in Clinical and experimental immunology (01-02-2006)
    “…4-1BB ligand (4-1BBL) expressed on antigen-presenting cells interacts with 4-1BB on activated T cells (especially CD8 super(+) cells) and co-stimulates the…”
    Get full text
    Journal Article
  13. 13

    Effects of interleukin 4 on CD25 super(+)CD4 super(+) regulatory T cell function by Maerten, P, Shen, C, Bullens, DMA, Van Assche, G, Van Gool, S, Geboes, K, Rutgeerts, P, Ceuppens, J L

    Published in Journal of autoimmunity (01-09-2005)
    “…CD25 super(+)CD4 super(+) regulatory T cells (Tregs) contribute to the maintenance of peripheral tolerance against self and non-self. The modulatory effects of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease by Maerten, Philippe, Geboes, Karel, Hertogh, Gert De, Shen, Chong, Cadot, Pascal, Bullens, Dominique M.A, Assche, Gert Van, Penninckx, Freddy, Rutgeerts, Paul, Ceuppens, Jan L

    Published in Clinical immunology (Orlando, Fla.) (01-09-2004)
    “…4-1BB ligand (L) expressed on antigen presenting cells (APC) interacts with 4-1BB, expressed on activated T cells and this interaction costimulates T cells to…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Contribution of endoscopy in palliative oncology (endoprosthesis, photodynamic therapy, parenteral nutrition by Maerten, P, El Wafa Abdou, A, Kessler-Brondolo, V, Doron, M, Ortner, M A

    Published in Revue médicale suisse (18-01-2006)
    “…The aim of this review is to give an overview of palliative endoscopic treatment options in patients with advanced cancers of the esophagus, stomach, pancreas…”
    Get more information
    Journal Article
  19. 19

    Targeting of costimulatory molecules as a therapeutic approach in inflammatory bowel disease by Maerten, Philippe, Liu, Zhanju, Ceuppens, Jan L

    “…Crohn's disease and ulcerative colitis are inflammatory bowel diseases (IBD) of unknown pathogenesis, for which no curative treatment is currently available…”
    Get full text
    Journal Article
  20. 20

    In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease by Colpaert, Stefaan, Vastraelen, Kathleen, Liu, Zhanju, Maerten, Philippe, Shen, Chong, Penninckx, Freddy, Geboes, Karel, Rutgeerts, Paul, Ceuppens, Jan L

    Published in European cytokine network (Montrouge) (01-10-2002)
    “…Crohn's disease is an inflammatory disease of the gut in which tumour necrosis factor (TNF) and T helper 1 (Th1) cytokines (interleukin (IL)-12, interferon…”
    Get more information
    Journal Article